Related Experiment Video
Updated: Apr 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-122 mimic transfection contributes to apoptosis in HepG2 cells
Hongyan Huang1, Yueyong Zhu1, Shaoyang Li2
1Liver Diseases Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, P.R. China.
Abstract:
There is currently a requirement for effective treatment strategies for human hepatocellular carcinoma (HCC), a leading cause of cancer‑associated mortality. MicroRNA-122 (miR-122), a repressor of the endogenous apoptosis regulator Bcl‑w, is frequently downregulated in HCC. Thus, it is hypothesized that the activation of miR‑122 may induce selective hepatocellular apoptosis via caspase activation in a model of HCC. In the present study, an miR‑122 mimic transfection was performed in HepG2 cells, and used to investigate the role and therapeutic potential of miR‑122 in the regulation of HCC‑derived cell lines. The apoptotic rates of HepG2 cells were significantly increased following miR‑122 mimic transfection. Reverse transcription‑polymerase chain reaction analysis revealed that Bcl‑w mRNA was significantly reduced, while the mRNA levels of caspase‑9 and caspase‑3 were markedly increased. The immunocytochemistry results supported the mRNA trends. Collectively, the present results suggest that endogenous miR‑122 contributes to HepG2 apoptosis and that transfection of mimic miR‑122 normalizes apoptotic levels in a model of HCC.
Insights
MicroRNA-122 (miR-122) restoration can induce cancer cell death in hepatocellular carcinoma (HCC) models. This study shows miR-122 mimic transfection increases apoptosis in HCC cells by targeting Bcl-w and activating caspases.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a major cause of cancer mortality.
- MicroRNA-122 (miR-122) is downregulated in HCC and represses Bcl-w, an apoptosis regulator.
- Restoring miR-122 may offer a therapeutic strategy for HCC.
Purpose of the Study:
- To investigate the role and therapeutic potential of miR-122 in HCC.
- To determine if miR-122 activation induces selective hepatocellular apoptosis via caspase activation.
Main Methods:
- Transfection of HepG2 cells with an miR-122 mimic.
- Assessing apoptotic rates using assays.
- Analyzing Bcl-w, caspase-9, and caspase-3 mRNA levels via RT-PCR.
- Confirming protein expression trends with immunocytochemistry.
Main Results:
- miR-122 mimic transfection significantly increased HepG2 cell apoptosis.
- Bcl-w mRNA levels were significantly reduced post-transfection.
- mRNA levels of caspase-9 and caspase-3 were markedly increased.
- Immunocytochemistry results corroborated the observed mRNA trends.
Conclusions:
- Endogenous miR-122 contributes to apoptosis in HepG2 cells.
- Transfecting with an miR-122 mimic normalizes apoptotic levels in an HCC model.
- miR-122 holds potential as a therapeutic agent for hepatocellular carcinoma.
Related Concept Videos
MicroRNAs
MicroRNAs

